Twist Bioscience Corp (TWST)
45.52
+0.10
(+0.22%)
USD |
NASDAQ |
Nov 07, 16:00
45.51
-0.01
(-0.02%)
After-Hours: 20:00
Twist Bioscience Revenue (TTM): 295.21M for June 30, 2024
Revenue (TTM) Chart
Historical Revenue (TTM) Data
Date | Value |
---|---|
June 30, 2024 | 295.21M |
March 31, 2024 | 277.49M |
December 31, 2023 | 262.36M |
September 30, 2023 | 245.11M |
June 30, 2023 | 235.47M |
March 31, 2023 | 227.84M |
December 31, 2022 | 215.79M |
September 30, 2022 | 203.56M |
June 30, 2022 | 184.21M |
March 31, 2022 | 163.11M |
December 31, 2021 | 146.19M |
September 30, 2021 | 132.33M |
June 30, 2021 | 126.82M |
Date | Value |
---|---|
March 31, 2021 | 113.00M |
December 31, 2020 | 101.10M |
September 30, 2020 | 90.10M |
June 30, 2020 | 73.40M |
March 31, 2020 | 65.80M |
December 31, 2019 | 60.06M |
September 30, 2019 | 54.39M |
June 30, 2019 | 47.06M |
March 31, 2019 | 40.00M |
December 31, 2018 | 32.61M |
September 30, 2018 | 25.43M |
June 30, 2018 | 20.49M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
60.06M
Minimum
Dec 2019
295.21M
Maximum
Jun 2024
169.42M
Average
163.11M
Median
Mar 2022
Revenue (TTM) Benchmarks
ResMed Inc | 4.807B |
RxSight Inc | 115.18M |
Perspective Therapeutics Inc | -- |
Xtant Medical Holdings Inc | 110.94M |
Catheter Precision Inc | 0.436M |